Products

The quality and safety of our products are our top priorities.

Ingenus was born in 2010, came to market in 2012 and we are continuously expanding our roster of high impact generic pharmaceutical products. We’ve built Ingenus on a foundation of innovation and collaboration to meet the unique needs of U.S. consumers. Our expansive generic product focus proves it.
With our team of over 140 developers and scientists, Ingenus today is poised to file 15- 25 ANDAs per year.
Name
Strength
NDC/SKU Numbers
Case Pack
TE Rating
Image
Carboplatin Injection
450 mg, 45 mL Injection
50742-0447-45
72
AP
//
600 mg, 60 mL Injection
50742-0448-60
56
AP
Clofarabine Injection
20 mg, 20 mL Injection
50742-0512-20
126
AP
Cyclophosphamide Injection
500 mg/2.5 mL (200 mg/mL)
50742-0519-02
126
None
//
1 g/5 mL (200 mg/mL)
50742-0520-05
126
None
Decitabine for Injection
50 mg/vial
50742-0430-01
96
AP
Docetaxel Injection, USP
20 mg, 2 mL Injection
50742-0428-02
72
AP
//
80 mg, 8 mL Injection
50742-0431-08
72
AP
//
160 mg, 16 mL Injection
50742-0463-16
72
AP
Irinotecan Injection, USP
40 mg, 2 mL Injection, USP
50742-0401-02
216
AP
//
100 mg, 5 mL Injection, USP
50742-0402-05
216
AP
Levoleucovorin Injection
175 mg, 17.5 mL Injection
50742-0494-17
96
AP
//
250 mg, 25 mL Injection
50742-0495-25
96
AP
Oxaliplatin Injection, USP
50 mg, 10 mL Injection
50742-0405-10
96
AP
//
100 mg, 20 mL Injection
50742-0406-20
96
AP
Palonosetron HCl Injection
0.25 mg, 5 mL Injection
50742-0485-05
12
AP
Zoledronic Acid Injection
4 mg, 5 mL Injection
50742-0416-05
96
AP